Search specific laws and standards for prescribing prescription drugs and for addressing medication errors for your state or region, and reflect on these as you review the scenario assigned by your Instructor.

Consider the ethical and legal implications of the scenario for all stakeholders involved, such as the prescriber, pharmacist, patient, and patient’s family.

• Think about two strategies that you, as an advanced practice nurse, would use to guide your ethically and legally responsible decision-making in this scenario, including whether you would disclose any medication errors.
• Write a paper that addresses the following:
• Explain the ethical and legal implications of the scenario you selected on all stakeholders involved, such as the prescriber, pharmacist, patient, and patient’s family.
• Describe strategies to address disclosure and nondisclosure as identified in the scenario you selected. Be sure to reference laws specific to your state.
• Explain two strategies that you, as an advanced practice nurse, would use to guide your decision making in this scenario, including whether you would disclose your error. Be sure to justify your explanation. 

Explain the process of writing prescriptions, including strategies to minimize medication errors.

SCENARIO

• TF is an 18-month-old boy who was admitted to your hospital for failure to thrive and losing 6 lbs. You have found that he has extreme blockage throughout his GI system with severe impaction throughout. He is in a great deal of pain and is screaming. His parents are adamant that they do not want treatments due to religious beliefs. They have stated that they boy’s grandfather, an elder in their church, is on his way to pray over the boy and heal him.
• Resources:
• Rosenthal, L. D., & Burchum, J. R. (2021). Lehne’s pharmacotherapeutics for advanced practice nurses and physician assistants (2nd ed.) St. Louis, MO: Elsevier.
• Chapter 1, “Prescriptive Authority” (pp. 1–3)

Chapter 2, “Rational Drug Selection and Prescription Writing” (pp. 4–7)

Chapter 3, “Promoting Positive Outcomes of Drug Therapy” (pp. 8–12)

• Chapter 4, “Pharmacokinetics, Pharmacodynamics, and Drug Interactions” (pp. 13–33)

Chapter 5, “Adverse Drug Reactions and Medication Errors” (pp. 34–42)

Chapter 6, “Individual Variation in Drug Response” (pp. 43–45)

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=1300

https://www.deadiversion.usdoj.gov/drugreg/practioners/index.html

• http://www.legalsideofpain.com/uploads/pract_manual090506.pdf